EA200971132A1 - Фармацевтическая композиция с пролонгированным высвобождением, приготовленная из микрочастиц - Google Patents
Фармацевтическая композиция с пролонгированным высвобождением, приготовленная из микрочастицInfo
- Publication number
- EA200971132A1 EA200971132A1 EA200971132A EA200971132A EA200971132A1 EA 200971132 A1 EA200971132 A1 EA 200971132A1 EA 200971132 A EA200971132 A EA 200971132A EA 200971132 A EA200971132 A EA 200971132A EA 200971132 A1 EA200971132 A1 EA 200971132A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- microparticles
- pharmaceutical composition
- prolonged delivery
- microns
- moreover
- Prior art date
Links
- 239000011859 microparticle Substances 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000002035 prolonged effect Effects 0.000 title abstract 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 2
- 229920001577 copolymer Polymers 0.000 abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 235000014655 lactic acid Nutrition 0.000 abstract 1
- 239000004310 lactic acid Substances 0.000 abstract 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Фармацевтическая композиция, приготовленная из микрочастиц, для пролонгированного высвобождения действующего вещества, по меньшей мере, в течение периода, охватывающего шестой месяц после инъекции указанной композиции, причем указанная композиция содержит группу микрочастиц, изготовленных из сополимера типа PLGA, который включает действующее вещество в форме водонерастворимой соли пептида; кроме того, указанный сополимер включает по меньшей мере 75% молочной кислоты и имеет характеристическую вязкость между 0,1 и 0,9 дл/г согласно измерению в хлороформе при 25°С и при концентрации полимера 0,5 г/дл; помимо этого указанные микрочастицы имеют распределение по размеру, определенное следующим образом: D (v,0.1) - между 10 и 30 мкм, D (v,0.5) - между 30 и 70 мкм, D (v,0.9) - между 50 и 110 мкм.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07109767 | 2007-06-06 | ||
| IB2007054372 | 2007-10-27 | ||
| PCT/IB2008/052241 WO2008149320A2 (en) | 2007-06-06 | 2008-06-06 | Slow release pharmaceutical composition made of microparticles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200971132A1 true EA200971132A1 (ru) | 2010-04-30 |
| EA019284B1 EA019284B1 (ru) | 2014-02-28 |
Family
ID=40032512
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200971132A EA019284B1 (ru) | 2007-06-06 | 2008-06-06 | Фармацевтическая композиция с пролонгированным высвобождением, приготовленная из микрочастиц |
Country Status (32)
| Country | Link |
|---|---|
| US (4) | US10166181B2 (ru) |
| EP (3) | EP2500014B2 (ru) |
| JP (1) | JP5419169B2 (ru) |
| KR (1) | KR101631475B1 (ru) |
| CN (1) | CN101677959B (ru) |
| AP (1) | AP3000A (ru) |
| AU (1) | AU2008259411B2 (ru) |
| BR (1) | BRPI0812250B8 (ru) |
| CA (1) | CA2688478C (ru) |
| CO (1) | CO6251234A2 (ru) |
| CY (2) | CY1118434T1 (ru) |
| DK (2) | DK2500014T4 (ru) |
| EA (1) | EA019284B1 (ru) |
| ES (2) | ES2611020T3 (ru) |
| FI (1) | FI2500014T4 (ru) |
| HR (2) | HRP20181854T4 (ru) |
| HU (2) | HUE031550T2 (ru) |
| IL (1) | IL202501A (ru) |
| LT (2) | LT2164467T (ru) |
| MA (1) | MA31422B1 (ru) |
| ME (1) | ME00959B (ru) |
| MX (1) | MX2009012856A (ru) |
| MY (1) | MY150450A (ru) |
| NZ (1) | NZ582423A (ru) |
| PL (2) | PL2164467T3 (ru) |
| PT (2) | PT2500014T (ru) |
| RS (2) | RS58248B1 (ru) |
| SI (2) | SI2500014T2 (ru) |
| TN (1) | TN2009000476A1 (ru) |
| UA (1) | UA99830C2 (ru) |
| WO (1) | WO2008149320A2 (ru) |
| ZA (1) | ZA200907940B (ru) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2611020T3 (es) | 2007-06-06 | 2017-05-04 | Debiopharm Research & Manufacturing Sa | Composición farmacéutica de liberación lenta hecha de micropartículas |
| PT105270B (pt) | 2010-08-26 | 2012-05-31 | Domino Ind Ceramicas S A | Camada de sílica com libertação lenta de fragrância, telha cerâmica e respectivo processo de produção |
| CN105267153B (zh) * | 2015-11-27 | 2018-05-11 | 上海苏豪逸明制药有限公司 | 一种曲普瑞林缓释微粒及其制备方法 |
| CN105797134B (zh) * | 2016-03-29 | 2019-06-14 | 浙江圣兆药物科技股份有限公司 | 一种难溶亮丙瑞林缓释制剂 |
| WO2018083633A1 (en) | 2016-11-02 | 2018-05-11 | Debiopharm International, S.A. | Methods for improving anti-cd37 immunoconjugate therapy |
| KR102402639B1 (ko) | 2017-11-24 | 2022-05-26 | 삼성전자주식회사 | 전자 장치 및 그의 통신 방법 |
| CN111000798B (zh) * | 2019-12-26 | 2021-11-23 | 四川恒博生物科技有限公司 | 一种采用原位凝胶技术的犬用非手术去势注射液 |
| IT202000017191A1 (it) | 2020-07-15 | 2022-01-15 | Xbrane Biopharma Ab | Procedimento senza acqua per preparare una composizione farmaceutica per un rilascio più prolungato e controllato di triptorelina o di un suo sale |
| TW202504578A (zh) | 2023-07-20 | 2025-02-01 | 荷蘭商輝凌責任有限公司 | 緩釋載藥微粒 |
| WO2025099253A1 (en) * | 2023-11-08 | 2025-05-15 | Debiopharm International Sa | Novel composition |
| WO2025180339A1 (zh) * | 2024-02-29 | 2025-09-04 | 珠海市华海康医药科技有限责任公司 | 一种双羟萘酸盐药物缓释微球及其制备方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3678308D1 (de) | 1985-02-07 | 1991-05-02 | Takeda Chemical Industries Ltd | Verfahren zur herstellung von mikrokapseln. |
| US4897268A (en) * | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
| GB2209937B (en) | 1987-09-21 | 1991-07-03 | Depiopharm S A | Water insoluble polypeptides |
| US5225205A (en) | 1989-07-28 | 1993-07-06 | Debiopharm S.A. | Pharmaceutical composition in the form of microparticles |
| CH679207A5 (ru) * | 1989-07-28 | 1992-01-15 | Debiopharm Sa | |
| MY107937A (en) | 1990-02-13 | 1996-06-29 | Takeda Chemical Industries Ltd | Prolonged release microcapsules. |
| CH683149A5 (fr) * | 1991-07-22 | 1994-01-31 | Debio Rech Pharma Sa | Procédé pour la préparation de microsphères en matériau polymère biodégradable. |
| FR2693905B1 (fr) * | 1992-07-27 | 1994-09-02 | Rhone Merieux | Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues. |
| JP3277342B2 (ja) | 1992-09-02 | 2002-04-22 | 武田薬品工業株式会社 | 徐放性マイクロカプセルの製造法 |
| CA2172507C (en) * | 1993-10-22 | 2008-12-02 | Jeffrey L. Cleland | Methods and compositions for microencapsulation of antigens for use as vaccines |
| US5945128A (en) * | 1996-09-04 | 1999-08-31 | Romano Deghenghi | Process to manufacture implants containing bioactive peptides |
| AR012448A1 (es) | 1997-04-18 | 2000-10-18 | Ipsen Pharma Biotech | Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada |
| US6573238B2 (en) | 1997-11-07 | 2003-06-03 | Chiron Corporation | Method for producing sustained-release formulations |
| TWI284048B (en) * | 2000-01-27 | 2007-07-21 | Zentaris Ag | Compressed microparticles for dry injection |
| US20040170665A1 (en) * | 2000-06-02 | 2004-09-02 | Allergan, Inc. | Intravitreal botulinum toxin implant |
| CA2463358C (fr) * | 2001-10-10 | 2012-03-13 | Pierre Fabre Medicament | Microspheres biodegradables a liberation prolongee et leur procede de preparation |
| CA2523830A1 (en) † | 2003-04-30 | 2004-11-11 | Debiopharm S.A. | Methods and compositions using gonadotropin hormone releasing hormone |
| KR100466637B1 (ko) * | 2003-06-26 | 2005-01-13 | 주식회사 펩트론 | 서방성 미립구의 혼합 제형을 연속한 단일 공정으로제조하는 방법 |
| FR2865938B1 (fr) * | 2004-02-05 | 2006-06-02 | Sod Conseils Rech Applic | Formulation retard solide comprenant de l'acetate de triptoreline |
| WO2007071395A1 (en) | 2005-12-22 | 2007-06-28 | Novartis Ag | Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers |
| ES2611020T3 (es) | 2007-06-06 | 2017-05-04 | Debiopharm Research & Manufacturing Sa | Composición farmacéutica de liberación lenta hecha de micropartículas |
-
2008
- 2008-06-06 ES ES08763237.8T patent/ES2611020T3/es active Active
- 2008-06-06 EP EP12172232.6A patent/EP2500014B2/en active Active
- 2008-06-06 PL PL08763237T patent/PL2164467T3/pl unknown
- 2008-06-06 JP JP2010510946A patent/JP5419169B2/ja active Active
- 2008-06-06 EA EA200971132A patent/EA019284B1/ru unknown
- 2008-06-06 CA CA2688478A patent/CA2688478C/en active Active
- 2008-06-06 UA UAA200913838A patent/UA99830C2/ru unknown
- 2008-06-06 EP EP08763237.8A patent/EP2164467B1/en not_active Revoked
- 2008-06-06 EP EP18186642.7A patent/EP3431077A1/en active Pending
- 2008-06-06 MY MYPI20094886 patent/MY150450A/en unknown
- 2008-06-06 ES ES12172232T patent/ES2694401T5/es active Active
- 2008-06-06 MX MX2009012856A patent/MX2009012856A/es active IP Right Grant
- 2008-06-06 BR BRPI0812250A patent/BRPI0812250B8/pt active IP Right Grant
- 2008-06-06 HU HUE08763237A patent/HUE031550T2/en unknown
- 2008-06-06 PT PT12172232T patent/PT2500014T/pt unknown
- 2008-06-06 SI SI200832014T patent/SI2500014T2/sl unknown
- 2008-06-06 RS RS20181349A patent/RS58248B1/sr unknown
- 2008-06-06 LT LTEP08763237.8T patent/LT2164467T/lt unknown
- 2008-06-06 KR KR1020107000176A patent/KR101631475B1/ko active Active
- 2008-06-06 AU AU2008259411A patent/AU2008259411B2/en active Active
- 2008-06-06 AP AP2009005088A patent/AP3000A/xx active
- 2008-06-06 CN CN200880018833.3A patent/CN101677959B/zh active Active
- 2008-06-06 RS RS20170032A patent/RS55591B1/sr unknown
- 2008-06-06 DK DK12172232.6T patent/DK2500014T4/da active
- 2008-06-06 HU HUE12172232A patent/HUE040391T2/hu unknown
- 2008-06-06 WO PCT/IB2008/052241 patent/WO2008149320A2/en not_active Ceased
- 2008-06-06 HR HRP20181854TT patent/HRP20181854T4/hr unknown
- 2008-06-06 SI SI200831754A patent/SI2164467T1/sl unknown
- 2008-06-06 PT PT87632378T patent/PT2164467T/pt unknown
- 2008-06-06 LT LTEP12172232.6T patent/LT2500014T/lt unknown
- 2008-06-06 NZ NZ582423A patent/NZ582423A/en unknown
- 2008-06-06 US US12/601,649 patent/US10166181B2/en active Active
- 2008-06-06 ME MEP-2009-341A patent/ME00959B/me unknown
- 2008-06-06 PL PL12172232.6T patent/PL2500014T5/pl unknown
- 2008-06-06 DK DK08763237.8T patent/DK2164467T3/en active
- 2008-06-06 FI FIEP12172232.6T patent/FI2500014T4/fi active
- 2008-06-06 HR HRP20161785TT patent/HRP20161785T1/hr unknown
-
2009
- 2009-11-09 TN TNP2009000476A patent/TN2009000476A1/fr unknown
- 2009-11-11 ZA ZA200907940A patent/ZA200907940B/xx unknown
- 2009-12-01 MA MA32391A patent/MA31422B1/fr unknown
- 2009-12-02 CO CO09137855A patent/CO6251234A2/es not_active Application Discontinuation
- 2009-12-03 IL IL202501A patent/IL202501A/en active IP Right Grant
-
2017
- 2017-01-17 CY CY20171100060T patent/CY1118434T1/el unknown
-
2018
- 2018-11-07 CY CY181101171T patent/CY1120891T1/el unknown
- 2018-11-15 US US16/192,674 patent/US20190192423A1/en not_active Abandoned
-
2022
- 2022-09-15 US US17/932,621 patent/US20230082575A1/en not_active Abandoned
-
2024
- 2024-12-03 US US18/967,155 patent/US20250205148A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200971132A1 (ru) | Фармацевтическая композиция с пролонгированным высвобождением, приготовленная из микрочастиц | |
| CY1109425T1 (el) | Φαρμακευτικες συνθεσεις για τη χορηγηση με ελεγχομενη αποδεσμευση βιολογικα δραστικων ενωσεων | |
| BR112014014599A2 (pt) | polímeros de alfa-aminoamidina e uso dos mesmos | |
| RU2011103437A (ru) | Фармацевтическая композиция, содержащая микрочастицы с поверхностным покрытием | |
| MX2014005820A (es) | Forma de dosis farmaceutica oral a prueba de manipulacion que comprende un agente antagonista y/o repelente opioide, oxido de polialquileno y un polimero anionico. | |
| WO2008107149A3 (de) | Darreichungsform mit erschwertem missbrauch | |
| SI2659881T1 (en) | Formulation of the delayed release medicinal product | |
| Patra et al. | Nanodelivery and anticancer effect of a limonoid, nimbolide, in breast and pancreatic cancer cells | |
| ATE382337T1 (de) | Bioabsorbierbare pharmazeutische zusammensetzung enthaltend einen plga-copolymer | |
| SA520412229B1 (ar) | تركيبات صيدلية لها فترة إطلاق مُختارة | |
| WO2012092486A3 (en) | Modified release benzimidazole formulations | |
| FI3229776T3 (fi) | Farmaseuttinen koostumus, joka yhdistää ainakin kaksi erillistä nanopartikkelia ja farmaseuttisen yhdisteen, sen valmistus ja käytöt | |
| WO2012172433A3 (en) | A sustained -release composition containing a melanocortin receptor ligand as the active ingredient | |
| WO2009145594A3 (ko) | 약물전달체 | |
| WO2008081829A1 (ja) | 難水溶性薬物の溶解性維持用アミノアルキルメタアクリレートコポリマーｅ | |
| EA200801259A1 (ru) | Способ получения препарата инсулина для перорального применения | |
| EA201390911A1 (ru) | Фармацевтическая композиция, содержащая растительное действующее вещество | |
| EA201290983A1 (ru) | Пероральные фармацевтические дисперсные композиции | |
| WO2011126327A3 (en) | Pharmaceutical composition with controlled-release properties comprising mosapride or levodropropizine, and preparing method thereof | |
| WO2010113176A3 (en) | Novel copolymers for controlled release delivery system | |
| CN104398527A (zh) | 一种注射用磺胺甲噁唑的药物组合物 | |
| Hong et al. | In vivo and in vitro testing of the efficacy of a novel drug delivery fabric | |
| UA96137C2 (ru) | Лекарственная форма с модифицированным высвобождением 3-гидрокси-6-метил-2-этилпиридина сукцината (мексидол) и способ ее приготовления | |
| TH117318A (th) | เวเฟอร์ซึ่งประกอบรวมด้วยสเตียรอยด์ฮอร์โมน |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC4A | Registration of transfer of a eurasian patent by assignment |